Moreover, a self-assembling vehicle-free multi-component antitumor nanovaccine (SVMAV) loaded with R848 and STAT3 inhibitors could effectively migrate into lymph nodes, promote CD8+ T cell response and DC function not only in primary melanoma, but also in lung metastasis. Here, CD8A is linked to melanoma.